1
|
Sakata K, Yamamoto CAP, Prakosa A, Tice BM, Ali SY, Loeffler S, Kholmovski EG, Sinha SK, Marine JE, Calkins H, Spragg DD, Trayanova NA. Digital twins enable stratification of persistent atrial fibrillation patients for ablation diminishing unnecessary heart damage. NPJ Digit Med 2025; 8:256. [PMID: 40335620 PMCID: PMC12059054 DOI: 10.1038/s41746-025-01625-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2024] [Accepted: 04/09/2025] [Indexed: 05/09/2025] Open
Abstract
Pulmonary vein isolation (PVI), the standard-of-care for atrial fibrillation (AF), is effective even in some persistent AF (PsAF) patients despite atrial fibrosis proliferation, suggesting that PVI could not only be isolating triggers but diminishing arrhythmogenic substrates. Left atrial (LA) posterior wall isolation is the prevalent adjunctive strategy aiming to address PsAF arrhythmogenesis, however, its outcomes vary widely. To explore why current PsAF ablation treatments have limited success and under what circumstances each treatment is most effective, we utilized patient-specific heart digital twins of PsAF patients incorporating fibrosis distributions to virtually implement versions of PVI (individual ostial to wide antral) and posterior wall isolation. In most digital-twins (60%) PVI greatly decreased LA substrate arrhythmogenicity without the need of wider lesions or posterior wall isolation. Using digital-twin findings, a strategy was developed to stratify PsAF patients to an appropriate ablation option based on fibrosis features, thus potentially avoiding unnecessary heart damage.
Collapse
Affiliation(s)
- Kensuke Sakata
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA
| | | | - Adityo Prakosa
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA
| | - Brock M Tice
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA
| | - Syed Yusuf Ali
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA
| | - Shane Loeffler
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA
| | - Eugene G Kholmovski
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA
| | - Sunil Kumar Sinha
- Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Joseph E Marine
- Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Hugh Calkins
- Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - David D Spragg
- Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| | - Natalia A Trayanova
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
| |
Collapse
|
2
|
Vatsaraj I, Mohsen Y, Grüne L, Steffens L, Loeffler S, Horlitz M, Stöckigt F, Trayanova N. 12 lead surface ECGs as a surrogate of atrial electrical remodeling - a deep learning based approach. J Electrocardiol 2025; 89:153862. [PMID: 39742814 PMCID: PMC11929969 DOI: 10.1016/j.jelectrocard.2024.153862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2024] [Revised: 11/02/2024] [Accepted: 12/13/2024] [Indexed: 01/04/2025]
Abstract
BACKGROUND AND PURPOSE Atrial fibrillation (AF), a common arrhythmia, is linked with atrial electrical and structural changes, notably low voltage areas (LVAs) which are associated with poor ablation outcomes and increased thromboembolic risk. This study aims to evaluate the efficacy of a deep learning model applied to 12‑lead ECGs for non-invasively predicting the presence of LVAs, potentially guiding pre-ablation strategies and improving patient outcomes. METHODS A retrospective analysis was conducted on 204 AF patients, who underwent catheter ablation. Pre-procedural sinus rhythm ECGs and electroanatomical maps (EAM) were utilized alongside demographic data to train a deep learning model combining Long Short-Term Memory networks and Convolutional Neural Networks with a cross-attention layer. Model performance was evaluated using a 5-fold cross-validation strategy. RESULTS The model effectively identified the presence of LVA on the examined atrial walls, achieving accuracies of 78 % for both the anterior and posterior walls, and 82 % for the LA roof. Moreover, it accurately predicted the global left atrial (LA) average voltage <0.7 mV, with an accuracy of 88 %. CONCLUSION The study showcases the potential of deep learning applied to 12‑lead ECGs to effectively predict regional LVAs and global LA voltage in AF patients non-invasively. This model offers a promising tool for the pre-ablation assessment of atrial substrate, facilitating personalized therapeutic strategies and potentially enhancing ablation success rates.
Collapse
Affiliation(s)
- Ishan Vatsaraj
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA.
| | - Yazan Mohsen
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA; Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany; Krankenhaus Porz am Rhein, Department of Cardiology, Electrophysiology and Rhythmology, Cologne, Germany
| | - Lukas Grüne
- Krankenhaus Porz am Rhein, Department of Cardiology, Electrophysiology and Rhythmology, Cologne, Germany
| | - Lucas Steffens
- Krankenhaus Porz am Rhein, Department of Cardiology, Electrophysiology and Rhythmology, Cologne, Germany
| | - Shane Loeffler
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA
| | - Marc Horlitz
- Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany; Krankenhaus Porz am Rhein, Department of Cardiology, Electrophysiology and Rhythmology, Cologne, Germany
| | - Florian Stöckigt
- Krankenhaus Porz am Rhein, Department of Cardiology, Electrophysiology and Rhythmology, Cologne, Germany; Department of Cardiology, University Hospital Bonn, Bonn, Germany
| | - Natalia Trayanova
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, MD, USA
| |
Collapse
|
3
|
Yavin H, Prasad M, Gordon J, Aksu T, Huang HD. Contemporary Trends in Pulsed Field Ablation for Cardiac Arrhythmias. J Cardiovasc Dev Dis 2024; 12:10. [PMID: 39852288 PMCID: PMC11766314 DOI: 10.3390/jcdd12010010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2024] [Revised: 12/17/2024] [Accepted: 12/27/2024] [Indexed: 01/26/2025] Open
Abstract
Pulsed field ablation (PFA) is a catheter-based procedure that utilizes short high voltage and short-duration electrical field pulses to induce tissue injury. The last decade has yielded significant scientific progress and quickened interest in PFA as an energy modality leading to the emergence of the clinical use of PFA technologies for the treatment of atrial fibrillation. It is generally agreed that more research is needed to improve our biophysical understanding of PFA for clinical cardiac applications as well as its potential as a potential alternative energy source to thermal ablation modalities for the treatment of other arrhythmias. In this review, we discuss the available preclinical and clinical evidence for PFA for atrial fibrillation, developments for ventricular arrhythmia (VA) ablation, and future perspectives.
Collapse
Affiliation(s)
- Hagai Yavin
- Department of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA; (H.Y.); (M.P.); (J.G.)
| | - Mark Prasad
- Department of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA; (H.Y.); (M.P.); (J.G.)
| | - Jonathan Gordon
- Department of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA; (H.Y.); (M.P.); (J.G.)
| | - Tolga Aksu
- Department of Cardiology, Yeditepe University Hospital, 34755 Istanbul, Turkey;
| | - Henry D. Huang
- Department of Cardiology, Rush University Medical Center, Chicago, IL 60612, USA; (H.Y.); (M.P.); (J.G.)
| |
Collapse
|
4
|
Lacaita PG, Beyer C, Plank F, Stühlinger M, Feuchtner GM. Late Enhancement Computed Tomography for Left Atrial Fibrosis Imaging: A Pilot "Proof-of-Concept" Study. Diagnostics (Basel) 2024; 14:2753. [PMID: 39682660 DOI: 10.3390/diagnostics14232753] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2024] [Revised: 12/02/2024] [Accepted: 12/04/2024] [Indexed: 12/18/2024] Open
Abstract
Background/Objective: Left atrial (LA) fibrosis imaging improves the guidance of LA catheter ablation. Cardiac computed tomography (CT) may be a reasonable alternative to CMR. The aim was to evaluate late enhancement (LE) fibrosis mapping by CT, and to correlate the results with low-voltage areas on electroanatomical mapping (EAM). Methods: In patients with atrial fibrillation who underwent 128-slice dual-source CT angiography (CTA) prior to LA catheter ablation, an additional LE-CT scan was performed 7 min after CTA. (1) Left atrial wall thickness (LAWT) was measured at three sites along the LA ridge. (2) Late enhancement (LE) was quantified co-axially aligned to LAWT and compared with low-voltage areas (LVA) on EAM. Results: Of 137 patients (age: 59.8 years; 27.7% females), 108 were included. The prevalence of LE was higher in patients with LAWT > 2 mm compared with 1.5 mm, with 78 (91.7%) vs. 77 (80.2%) (p = 0.022). Of 78 patients with LE, 60 (77.1%) had focal, 13 (16.5%) had diffuse, and 5 (6.3%) had mixed LE patterns. The CT density of focal LE was not different from that of diffuse patterns (104.2 +/- 21 HU vs. 98.9 +/- 18 HU; p = 0.360). Increasing LAWT and LE-HU were weakly correlated (r = 0.229; p = 0.041). LA wall artifacts had higher CT density compared with LE (154.1 HU vs. 114.2 HU; p = 0.002). The effective radiation dose was 0.95 mSv (range, 0.52-1.2 mSv) for LE-CT. The agreement of LE-CT was 80% for LVA < 0.5 mV and 86.6% for LVA < 0.7 mV in a subset of 30 patients. Conclusions: Left atrial fibrosis mapping by LE-CT is feasible. Late enhancement was found more frequently in LAWTs of more than 2 mm, and LE was correlated with increasing LA remodeling and low-voltage areas.
Collapse
Affiliation(s)
- Pietro G Lacaita
- Department of Radiology, Innsbruck Medical University, 6020 Innsbruck, Austria
| | - Christoph Beyer
- Department of Cardiology, Tyrol Clinicum Hall, 6060 Hall, Austria
| | - Fabian Plank
- Department of Cardiology, Tyrol Clinicum Hall, 6060 Hall, Austria
| | - Markus Stühlinger
- Department of Cardiology, Innsbruck Medical University, 6020 Innsbruck, Austria
| | - Gudrun M Feuchtner
- Department of Radiology, Innsbruck Medical University, 6020 Innsbruck, Austria
| |
Collapse
|
5
|
Mohsen Y, Großmann N, Draheim J, Horlitz M, Stöckigt F. Coronary sinus signal amplitude: A predictor of the atrial substrate and low voltage areas. Pacing Clin Electrophysiol 2024; 47:1425-1432. [PMID: 39248315 DOI: 10.1111/pace.15070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/17/2024] [Revised: 08/10/2024] [Accepted: 08/27/2024] [Indexed: 09/10/2024]
Abstract
BACKGROUND Low voltage areas (LVA) are pivotal in atrial fibrillation (AF) pathogenesis, influencing local left atrial LA excitation and perpetuating AF occurrences. While pulmonary vein isolation (PVI) with cryo-balloon (CB) ablation is effective for AF, it doesn't provide insights into the LA substrate or detect LVA, which affects ablation success rates. This study examines whether LA voltage and LVAs can be anticipated by analyzing the voltage signal amplitude at the coronary sinus (CS) catheter, which is standard in CB and radiofrequency ablation procedures. METHODS A retrospective analysis of 284 patients with recurrent AF undergoing RF catheter ablation was conducted at a high-volume EP center in Germany. The correlation between LA voltage and LVA with the CS signal was explored. RESULTS The signal amplitude in the CS significantly correlated with voltage in LA walls, particularly in the proximal CS (correlation coefficient ρ = 0.81, p < 0.001). A CS signal cut-off of 1.155 mV effectively predicted severe atrial LVAs (>40%) with a sensitivity of 90.7% and a specificity of 100%. While a threshold of 1.945 mV identified patients with no significant atrial LVAs (<5%) with a sensitivity of 88% and a specificity of 50% (AUC: 0.81, 95% CI: 0.71-0.89, p < 0.001). CONCLUSION The CS signal amplitude is associated with the LA voltage. Due to its potential as a diagnostic tool for atrial LVAs, the signal amplitude in the CS could provide valuable information about the LA substrate, especially when 3D mapping is not feasible.
Collapse
Affiliation(s)
- Yazan Mohsen
- Department of Cardiology, Electrophysiology and Rhythmology, Krankenhaus Porz am Rhein, Cologne, Germany
- Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany
| | - Nora Großmann
- Department of Cardiology, Electrophysiology and Rhythmology, Krankenhaus Porz am Rhein, Cologne, Germany
| | - Jennifer Draheim
- Department of Cardiology, Electrophysiology and Rhythmology, Krankenhaus Porz am Rhein, Cologne, Germany
| | - Marc Horlitz
- Department of Cardiology, Electrophysiology and Rhythmology, Krankenhaus Porz am Rhein, Cologne, Germany
- Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany
| | - Florian Stöckigt
- Department of Cardiology, Electrophysiology and Rhythmology, Krankenhaus Porz am Rhein, Cologne, Germany
- Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany
| |
Collapse
|
6
|
Ali SY, Mohsen Y, Mao Y, Sakata K, Kholmovski EG, Prakosa A, Yamamoto C, Loeffler S, Elia M, Zandieh G, Stöckigt F, Horlitz M, Sinha SK, Marine J, Calkins H, Sommer P, Sciacca V, Fink T, Sohns C, Spragg D, Trayanova N. Unipolar voltage electroanatomic mapping detects structural atrial remodeling identified by LGE-MRI. Heart Rhythm 2024:S1547-5271(24)03430-1. [PMID: 39396602 DOI: 10.1016/j.hrthm.2024.10.015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2024] [Revised: 10/05/2024] [Accepted: 10/08/2024] [Indexed: 10/15/2024]
Abstract
BACKGROUND In atrial fibrillation (AF) management, understanding left atrial (LA) substrate is crucial. While both electroanatomic mapping (EAM) and late gadolinium enhancement magnetic resonance imaging (LGE-MRI) are accepted methods for assessing the atrial substrate and are associated with ablation outcome, recent findings have highlighted discrepancies between low-voltage areas (LVAs) in EAM and LGE areas. OBJECTIVE The purpose of this study was to explore the relationship between LGE regions and unipolar and bipolar LVAs using multipolar high-density mapping. METHODS Twenty patients scheduled for AF ablation underwent preablation LGE-MRI. LA segmentation was conducted using a deep learning approach, which subsequently generated a 3-dimensional mesh integrating the LGE data. High-density EAM was performed in sinus rhythm for each patient. The electroanatomic map and LGE-MRI mesh were coregistered. LVAs were defined using cutoffs of 0.5 mV for bipolar voltage and 2.5 mV for unipolar voltage. The correspondence between LGE areas and LVAs in the LA was analyzed using confusion matrices and performance metrics. RESULTS A considerable 87.3% of LGE regions overlapped with unipolar LVAs, compared with only 16.2% overlap observed with bipolar LVAs. Across all performance metrics, unipolar LVAs outperformed bipolar LVAs in identifying LGE areas (precision: 78.6% vs 61.1%; sensitivity: 87.3% vs 16.2%; F1 score: 81.3% vs 26.0%; accuracy: 74.0% vs 35.3%). CONCLUSION Our findings demonstrate that unipolar LVAs strongly correlate with LGE regions. These findings support the integration of unipolar mapping alongside bipolar mapping into clinical practice. This would offer a nuanced approach to diagnose and manage AF by revealing critical insights into the complex architecture of the atrial substrate.
Collapse
Affiliation(s)
- Syed Yusuf Ali
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland
| | - Yazan Mohsen
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland; Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany
| | - Yuncong Mao
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland
| | - Kensuke Sakata
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland
| | - Eugene G Kholmovski
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland
| | - Adityo Prakosa
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland
| | - Carolyna Yamamoto
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland
| | - Shane Loeffler
- Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland
| | - Marianna Elia
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland
| | - Ghazal Zandieh
- Department of Radiology, Johns Hopkins Hospital, Baltimore, Maryland
| | - Florian Stöckigt
- Department of Cardiology, University Hospital Bonn, Bonn, Germany
| | - Marc Horlitz
- Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany
| | - Sunil Kumar Sinha
- Department of Cardiology, Heart and Vascular Institute, Johns Hopkins Hospital, Baltimore, Maryland
| | - Joseph Marine
- Department of Cardiology, Heart and Vascular Institute, Johns Hopkins Hospital, Baltimore, Maryland
| | - Hugh Calkins
- Department of Cardiology, Heart and Vascular Institute, Johns Hopkins Hospital, Baltimore, Maryland
| | - Philipp Sommer
- Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr- Universität Bochum, Bad Oeynhausen, Germany
| | - Vanessa Sciacca
- Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr- Universität Bochum, Bad Oeynhausen, Germany
| | - Thomas Fink
- Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr- Universität Bochum, Bad Oeynhausen, Germany
| | - Christian Sohns
- Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr- Universität Bochum, Bad Oeynhausen, Germany
| | - David Spragg
- Clinic for Electrophysiology, Herz- und Diabeteszentrum NRW, Ruhr- Universität Bochum, Bad Oeynhausen, Germany
| | - Natalia Trayanova
- Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland; Alliance for Cardiovascular Diagnostic and Treatment Innovation, Johns Hopkins University, Baltimore, Maryland.
| |
Collapse
|
7
|
Mohsen Y, Rottländer D, Großmann N, Lewandowski N, Horlitz M, Stöckigt F. Unraveling the interplay: early-stage atrial functional mitral regurgitation and left atrial electrical substrate in atrial fibrillation patients. Front Cardiovasc Med 2024; 11:1382570. [PMID: 39238500 PMCID: PMC11374646 DOI: 10.3389/fcvm.2024.1382570] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2024] [Accepted: 08/06/2024] [Indexed: 09/07/2024] Open
Abstract
Background Atrial fibrillation (AF) triggers atrial remodeling, impacting atrial function and ablation efficacy. This remodeling leads to atrial cardiomyopathy and dilatation, linked to mitral regurgitation, forming atrial functional mitral regurgitation (aFMR). Our study explores the relationship between early-stage-aFMR and the atrial electrical architecture, focusing on left atrial bipolar voltage and low-voltage areas (LVAs) in AF patients. Methods We enrolled 282 patients undergoing redo-PVI after AF recurrence post-PVI. Echocardiography was performed prior to ablation, and only patients with no, mild, or mild-to-moderate aFMR were included. Ablation used radiofrequency and a 3D mapping system, with atrial voltage documented on each atrial wall. LVAs were calculated using high-density maps, and patients were followed for 15 months. Results Significant differences in left atrial voltage and LVA extent were observed based on aFMR severity. Patients with aFMR 1 + had significantly lower atrial voltage compared to no-aFMR, but no significant increase in LVAs. Patients with aFMR 2 + showed lower voltage amplitudes in all atrial regions and larger LVAs compared to no-aFMR patients. AF recurrence was significantly higher in the aFMR group (62.9% vs. 48.3%, p = 0.027) within 1 year. aFMR was associated with AF recurrence after adjusting for sex, age, and AF types (HR: 1.517, 95% CI: 1.057-2.184, p = 0.025). Conclusion aFMR in AF patients may indicate progressive atrial remodeling and left atrial cardiomyopathy, characterized by reduced atrial voltage and increased LVAs. aFMR is linked to PVI outcomes, suggesting its consideration in AF therapy decision-making.
Collapse
Affiliation(s)
- Yazan Mohsen
- Department of Cardiology, Krankenhaus Porz am Rhein, Cologne, Germany
- Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany
| | - Dennis Rottländer
- Department of Cardiology, Krankenhaus Porz am Rhein, Cologne, Germany
- Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany
| | - Nora Großmann
- Department of Cardiology, Krankenhaus Porz am Rhein, Cologne, Germany
| | | | - Marc Horlitz
- Department of Cardiology, Krankenhaus Porz am Rhein, Cologne, Germany
- Department of Cardiology, Faculty of Health, School of Medicine, University Witten/Herdecke, Witten, Germany
| | - Florian Stöckigt
- Department of Cardiology, Krankenhaus Porz am Rhein, Cologne, Germany
- Department of Internal Medicine II, University Hospital Bonn, Bonn, Germany
| |
Collapse
|